Revisiting the WHO entity "myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2" in 74 patients: lack of eosinophilia and presence of monocytosis

被引：0
|
作者：
Steiner, L. [1 ]
Schwaab, J. [1 ]
Naumann, N. [1 ]
Jahwar, M. [1 ]
Kreil, S. [1 ]
Haferlach, T. [2 ]
Fabarius, A. [1 ]
Hofmann, W. -K. [1 ]
Cross, N. C. P. [3 ,4 ]
Reiter, A. [1 ]
Metzgeroth, G. [1 ]
机构：
[1] Univ Med Mannheim, Med Klin 3, Hamatol & Onkol, Mannheim, Germany
[2] Munchner Leukamielab, Munich, Germany
[3] Wessex Reg Genet Lab, Salisbury, Wilts, England
[4] Univ Southampton, Fac Med, Southampton, Hants, England
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
215
引用
收藏
页码：80 / 80
页数：1
相关论文
共 35 条
  • [1] Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2
    Pozdnyakova, Olga
    Orazi, Attilio
    Kelemen, Katalin
    King, Rebecca
    Reichard, Kaaren K.
    Craig, Fiona E.
    Quintanilla-Martinez, Leticia
    Rimsza, Lisa
    George, Tracy, I
    Horny, Hans-Peter
    Wang, Sa A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 155 (02) : 160 - 178
  • [2] Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
    Baer, Constance
    Muehlbacher, Verena
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    HAEMATOLOGICA, 2018, 103 (08) : E348 - E350
  • [3] Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
    Bain, Barbara J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 696 - 698
  • [4] Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB or FGFR1
    Dunphy, Cherie H.
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (01) : 44 - 51
  • [5] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Patterer, Verena
    Schnittger, Susanne
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    ANNALS OF HEMATOLOGY, 2013, 92 (06) : 759 - 769
  • [6] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Verena Patterer
    Susanne Schnittger
    Wolfgang Kern
    Torsten Haferlach
    Claudia Haferlach
    Annals of Hematology, 2013, 92 : 759 - 769
  • [7] Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review
    Savage, N.
    George, T. I.
    Gotlib, J.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (05) : 491 - 500
  • [8] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
    Romagnoli, Simone
    Bartalucci, Niccolo
    Gesullo, Francesca
    Balliu, Manjola
    Bonifacio, Stefania
    Fernandez, Anair Graciela Lema
    Mannelli, Francesco
    Bolognini, Davide
    Pelo, Elisabetta
    Mecucci, Cristina
    Guglielmelli, Paola
    Vannucchi, Alessandro Maria
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [9] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
    Simone Romagnoli
    Niccolò Bartalucci
    Francesca Gesullo
    Manjola Balliu
    Stefania Bonifacio
    Anair Graciela Lema Fernandez
    Francesco Mannelli
    Davide Bolognini
    Elisabetta Pelo
    Cristina Mecucci
    Paola Guglielmelli
    Alessandro Maria Vannucchi
    Biomarker Research, 9
  • [10] Clinicopathologic Study of Myeloid/Lymphoid Neoplasms with Altered PDGFRA, PGDFRB, FGFR1 and PCM1-JAK2
    Aqil, Barina
    Sukhanova, Madina
    Jennings, Lawrence
    Lu, Xinyan
    Chen, Yi-Hua
    Gao, Juehua
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 804 - 805
1234